Nuvation Bio Soars on Ibtrozi Success and Analyst Upgrades
Nuvation Bio shares jump 49% Wed. after strong Ibtrozi results and analyst upgrades, signaling growth potential in biotech and cancer treatments.
NOTRELOAD AI
Abbott Makes Major Move in Cancer Diagnostics with $21B Exact Sciences Acquisition
Abbott to acquire Exact Sciences for $21 billion, gaining leadership in cancer screening with Cologuard and expanding its diagnostics portfolio into fast-growing oncology segment.
Walmart Raises Annual Forecast After Strong Quarter, Plans Nasdaq Move
Walmart boosts 2025 forecast for second time as eCommerce grows 27%. Stock moving to Nasdaq in December as retailer expands tech focus.
RBC Upgrades Design Therapeutics on Strong 2026 Outlook
RBC Capital upgrades Design Therapeutics to Outperform with a new $13 price target, citing promising 2026 milestones, positive data potential, and long-term revenue upside.
U.S. Approves Major AI Chip Sales to UAE and Saudi Arabia
The U.S. greenlights the sale of up to 70,000 advanced AI chips to UAE and Saudi companies, reversing earlier restrictions and reshaping global AI competition.
Piper Sandler Begins Coverage of AeroVironment With Bullish Outlook
Piper Sandler initiates coverage of AeroVironment with an Overweight rating and $391 price target, highlighting strong growth prospects, innovation, and the impact of the BlueHalo acquisition.